900196586	900196586	CD	B-NP	O
|	|	NN	I-NP	O
TMMC	TMMC	NN	I-NP	O
|	|	NN	I-NP	O
30612183	30612183	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
364151	364151	CD	B-NP	O
|	|	CC	I-NP	O
3/25/2002	3/25/2002	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
ATRIAL	ATRIAL	NNP	I-NP	I-protein
FIBRILLATION	FIBRILLATION	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/27/2002	6/27/2002	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/1/2002	1/1/2002	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CONGESTIVE	CONGESTIVE	NNP	B-NP	O
HEART	HEART	NNP	I-NP	O
FAILURE	FAILURE	NNP	I-NP	O
.	.	.	O	O

SIGNIFICANT	SIGNIFICANT	NNP	B-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

CONGESTIVE	CONGESTIVE	NNP	B-NP	O
HEART	HEART	NNP	I-NP	O
FAILURE	FAILURE	NNP	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

ATRIAL	ATRIAL	NN	B-NP	O
FIBRILLATION	FIBRILLATION	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

URINARY	URINARY	NN	B-NP	O
TRACT	TRACT	NN	I-NP	O
INFECTION	INFECTION	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

DIABETES	DIABETES	NNS	B-NP	O
MELLITUS	MELLITUS	NNS	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
70-year-old	70-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
in	in	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Pikula	Pikula	NNP	I-NP	O
who	who	WP	B-NP	O
has	have	VBZ	B-VP	O
presumed	presume	VBN	I-VP	O
diastolic	diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
health	health	NN	B-NP	O
until	until	IN	B-PP	O
1/23	1/23	CD	B-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Dobubay	Dobubay	NNP	I-NP	O
Naicent	Naicent	NNP	I-NP	O
University	University	NNP	I-NP	O
Of	Of	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
flare	flare	NN	I-NP	O
of	of	IN	B-PP	O
Crohn	Crohn	NN	B-NP	O
's	's	POS	B-NP	O
ileitis	ileitis	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
Lasix	Lasix	NN	I-NP	O
and	and	CC	O	O
subsequently	subsequently	RB	B-NP	O
developed	develop	VBN	I-NP	O
fluid	fluid	NN	I-NP	O
retention	retention	NN	I-NP	O
with	with	IN	B-PP	O
gradual	gradual	JJ	B-NP	O
worsening	worsening	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	O	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
noted	note	VBD	B-VP	O
a	a	DT	B-NP	O
20	20	CD	I-NP	O
lb	lb	NN	I-NP	O
weight	weight	NN	I-NP	O
gain	gain	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
period	period	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
increasing	increase	VBG	B-VP	O
orthopnea	orthopnea	NN	B-NP	O
and	and	CC	O	O
increasing	increase	VBG	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
when	when	WRB	B-ADVP	O
getting	get	VBG	B-VP	O
dressed	dress	VBN	I-VP	O
or	or	CC	O	O
doing	do	VBG	B-VP	O
any	any	DT	B-NP	O
different	different	JJ	I-NP	O
movements	movement	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
clinic	clinic	NN	I-NP	O
on	on	IN	B-PP	O
8/3/02	8/3/02	CD	B-NP	O
and	and	CC	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
much	much	RB	B-NP	O
worse	worse	JJR	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
new	new	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
then	then	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
here	here	RB	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Peresvillee	Peresvillee	NNP	I-NP	O
Nawvine	Nawvine	NNP	I-NP	O
University	University	NNP	I-NP	O
Of	Of	IN	B-PP	O
Hospitals	Hospitals	NNP	B-NP	O
And	And	CC	O	O
Clinics	Clinics	NNP	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
most	most	RBS	I-NP	O
recent	recent	JJ	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
on	on	IN	B-PP	O
4/29/01	4/29/01	CD	B-NP	O
revealed	reveal	VBD	B-VP	O
mild	mild	JJ	B-ADJP	O
to	to	TO	B-PP	O
moderate	moderate	JJ	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
regional	regional	JJ	I-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
was	be	VBD	B-VP	O
estimated	estimate	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
suggesting	suggest	VBG	B-VP	O
a	a	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
diastolic	diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
and	and	CC	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
for	for	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
review	review	NN	I-NP	O
of	of	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
chest	chest	NN	B-NP	O
tightness	tightness	NN	I-NP	O
with	with	IN	B-PP	O
occasional	occasional	JJ	B-NP	O
palpitations	palpitation	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
experienced	experience	VBD	B-VP	O
no	no	DT	B-NP	O
dizziness	dizziness	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
syncope	syncope	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
recent	recent	JJ	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
nausea	nausea	NN	I-NP	O
or	or	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
report	report	VB	I-VP	O
chronic	chronic	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
diastolic	diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Crohn	Crohn	NNP	I-NP	O
's	's	POS	B-NP	O
colitis	colitis	NN	I-NP	O
diagnosed	diagnose	VBN	B-VP	O
in	in	IN	B-PP	O
1963	1963	CD	B-NP	O
,	,	,	O	O
-LRB-	-LRB-	HYPH	B-NP	B-protein
3	3	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
Right	Right	NN	I-NP	B-protein
breast	breast	NN	I-NP	I-protein
carcinoma	carcinoma	NN	I-NP	I-protein
stage	stage	NN	I-NP	I-protein
II	II	CD	I-NP	I-protein
previously	previously	RB	B-VP	O
treated	treat	VBN	I-VP	O
,	,	,	O	O
not	not	RB	O	O
currently	currently	RB	B-ADVP	O
active	active	JJ	B-ADJP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	O
4	4	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Diabetes	Diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	SYM	B-NP	B-protein
5	5	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
Obstructive	Obstructive	JJ	I-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	O
6	6	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Gastroesophageal	Gastroesophageal	JJ	I-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
7	7	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Hypercholesterolemia	Hypercholesterolemia	NNP	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NNP	B-NP	O
8	8	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Osteoarthritis	Osteoarthritis	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
prior	prior	JJ	I-NP	O
tobacco	tobacco	NN	I-NP	O
smoker	smoker	NN	I-NP	O
,	,	,	O	O
having	have	VBG	B-VP	O
smoked	smoke	VBN	I-VP	O
two	two	CD	B-NP	O
packs	pack	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
for	for	IN	B-PP	O
38	38	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
quit	quit	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
drink	drink	VB	I-VP	O
alcohol	alcohol	NN	B-NP	O
and	and	CC	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
use	use	VB	I-VP	O
any	any	DT	B-NP	O
recreational	recreational	JJ	I-NP	O
drugs	drug	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	life	NNS	I-NP	O
in	in	IN	B-PP	O
Di	Di	NNP	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
friend	friend	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
retired	retired	JJ	I-NP	O
x-ray	x-ray	JJ	I-NP	O
technician	technician	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Noncontributory	Noncontributory	JJ	B-ADJP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
medical	medical	JJ	I-NP	O
allergies	allergy	NNS	I-NP	O
include	include	VBP	B-VP	O
penicillin	penicillin	NN	B-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
causes	cause	VBZ	B-VP	O
a	a	DT	B-NP	O
rash	rash	NN	I-NP	O
,	,	,	O	O
Demerol	Demerol	NN	B-NP	O
and	and	CC	O	O
Dilaudid	Dilaudid	VBD	B-VP	O
causing	cause	VBG	I-VP	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Macrodantin	Macrodantin	NN	B-NP	B-protein
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
:	:	:	O	O
VITAL	VITAL	JJ	B-NP	O
SIGNS	SIGNS	NN	I-NP	O
:	:	:	O	O
Included	Include	VBD	B-VP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
97	97	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
76	76	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
90/60	90/60	CD	I-NP	O
,	,	,	I-NP	O
respiratory	respiratory	JJ	I-NP	O
rate	rate	NN	I-NP	O
28	28	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
saturation	saturation	NN	I-NP	O
of	of	IN	B-PP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

GENERAL	GENERAL	NN	B-NP	O
:	:	:	O	O
Physical	Physical	JJ	B-NP	O
examination	examination	NN	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
x3	x3	NN	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
,	,	,	O	O
having	have	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
while	while	IN	B-SBAR	O
sitting	sit	VBG	B-VP	O
up	up	RP	B-PRT	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Normocephalic	Normocephalic	JJ	B-NP	O
,	,	,	I-NP	O
atraumatic	atraumatic	JJ	I-NP	O
,	,	,	I-NP	O
pupils	pupil	NNS	I-NP	O
equal	equal	JJ	B-ADJP	O
,	,	,	O	O
round	round	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
reactive	reactive	JJ	B-NP	O
,	,	,	I-NP	O
extraocular	extraocular	JJ	I-NP	O
movements	movement	NNS	I-NP	O
were	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

NECK	NECK	NN	B-NP	O
:	:	:	O	O
Showed	Show	VBD	B-VP	O
jugular	jugular	JJ	B-NP	O
venous	venous	JJ	I-NP	O
distention	distention	NN	I-NP	O
to	to	TO	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
20	20	CD	I-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

CHEST	CHEST	NN	B-NP	O
:	:	:	O	O
Showed	Show	VBD	B-VP	O
crackles	crackle	NNS	B-NP	O
posteriorly	posteriorly	RB	B-NP	O
approximately	approximately	RB	I-NP	O
half	half	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
way	way	NN	I-NP	O
up	up	RP	B-PRT	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
Showed	Show	VBD	B-VP	O
an	an	DT	B-NP	O
irregular	irregular	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
prior	prior	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
aortic	aortic	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Showed	Show	VBD	B-VP	O
profound	profound	JJ	B-NP	O
obesity	obesity	NN	I-NP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
Showed	Show	VBD	B-VP	O
significant	significant	JJ	B-NP	O
pitting	pitting	NN	I-NP	O
edema	edema	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
calves	calf	NNS	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Showed	Show	VBD	B-VP	O
a	a	DT	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
7	7	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
31	31	CD	I-NP	O
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
148	148	CD	B-NP	O
.	.	.	O	O

Sodium	Sodium	NN	B-NP	O
was	be	VBD	B-VP	O
142	142	CD	B-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
3.9	3.9	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
56	56	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.3	1.3	CD	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
glucose	glucose	NN	I-NP	O
of	of	IN	B-PP	O
75	75	CD	B-NP	O
.	.	.	O	O

Liver	Liver	NN	B-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
were	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

CK	CK	NN	B-NP	B-protein
was	be	VBD	B-VP	O
44	44	CD	B-NP	O
and	and	CC	O	O
troponin	troponin	NN	B-NP	O
was	be	VBD	B-VP	O
0.02	0.02	CD	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
showed	show	VBD	B-VP	O
mild	mild	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
congestion	congestion	NN	I-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
infiltrates	infiltrate	NNS	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
72	72	CD	B-NP	O
,	,	,	O	O
otherwise	otherwise	RB	B-NP	O
no	no	DT	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
beside	beside	IN	B-PP	O
some	some	DT	B-NP	O
nonspecific	nonspecific	JJ	I-NP	O
ST-T	ST-T	NN	I-NP	O
wave	wave	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
showed	show	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
with	with	IN	B-PP	O
20-30	20-30	CD	B-NP	O
white	white	JJ	I-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
was	be	VBD	B-VP	O
leukocyte	leukocyte	NN	B-NP	O
esterase	esterase	NN	I-NP	O
positive	positive	JJ	B-ADJP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	B-cell_line
culture	culture	NN	I-NP	I-cell_line
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-	-	HYPH	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
IV	IV	NNP	B-NP	O
Lasix	Lasix	NNP	I-NP	O
along	along	IN	B-PP	O
with	with	IN	B-PP	O
Zaroxolyn	Zaroxolyn	NN	B-NP	B-protein
and	and	CC	O	O
responded	respond	VBD	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
brisk	brisk	JJ	I-NP	O
diuresis	diuresis	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
weight	weight	NN	I-NP	O
declined	decline	VBD	B-VP	O
by	by	IN	B-PP	O
approximately	approximately	RB	B-NP	O
5.2	5.2	CD	I-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
estimated	estimate	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
volume	volume	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
removed	remove	VBN	B-VP	O
was	be	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
15	15	CD	I-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
reported	report	VBN	I-VP	O
great	great	JJ	B-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
ambulate	ambulate	VB	I-VP	O
without	without	IN	B-PP	O
requiring	require	VBG	B-VP	O
supplemental	supplemental	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
Lasix	Lasix	NN	I-NP	O
and	and	CC	O	O
continued	continue	VBD	B-VP	O
her	her	PRP$	B-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
torsemide	torsemide	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
that	that	DT	B-NP	O
medication	medication	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Atrial	Atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
-	-	HYPH	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
new	new	JJ	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
while	while	IN	B-SBAR	O
being	be	VBG	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
clinic	clinic	NN	I-NP	O
on	on	IN	B-PP	O
8/3/02	8/3/02	CD	B-NP	O
.	.	.	O	O

Since	Since	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
known	know	VBN	I-VP	O
how	how	WRB	B-ADVP	O
long	long	JJ	O	O
the	the	DT	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
going	go	VBG	I-VP	O
on	on	IN	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
decision	decision	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
to	to	TO	B-VP	O
anticoagulate	anticoagulate	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
unfractionated	unfractionated	JJ	I-NP	O
heparin	heparin	NN	I-NP	O
while	while	IN	B-SBAR	O
starting	start	VBG	B-VP	O
anticoagulation	anticoagulation	NN	B-NP	O
with	with	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reached	reach	VBD	B-VP	O
a	a	DT	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
INR	INR	NN	I-NP	O
of	of	IN	B-PP	O
2.5	2.5	CD	B-NP	O
within	within	IN	B-PP	O
approximately	approximately	RB	B-NP	O
4-5	4-5	CD	I-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
IV	IV	CD	I-NP	O
heparin	heparin	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
INR	INR	NN	I-NP	O
was	be	VBD	B-VP	O
3.2	3.2	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
INR	INR	NNP	B-NP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
through	through	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Janousek	Janousek	NNP	I-NP	O
.	.	.	O	O

Currently	Currently	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
decision	decision	NN	I-NP	O
to	to	TO	B-VP	O
cardiovert	cardiovert	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
left	leave	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hands	hand	NNS	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Urinary	Urinary	JJ	B-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
-	-	HYPH	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
initial	initial	JJ	I-NP	O
urinalysis	urinalysis	NN	I-NP	O
indicated	indicate	VBD	B-VP	O
a	a	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

Subsequent	Subsequent	JJ	B-NP	O
urine	urine	NN	I-NP	O
culture	culture	NN	I-NP	O
grew	grow	VBD	B-VP	O
out	out	RP	B-PRT	O
E.	E.	NNP	B-NP	O
coli	coli	NNP	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
determined	determine	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
IV	IV	CD	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
p.o.	p.o.	FW	B-NP	O
cefixime	cefixime	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
completed	complete	VBD	B-VP	O
a	a	DT	B-NP	O
five-day	five-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
p.o.	p.o.	FW	B-NP	O
cefixime	cefixime	NN	I-NP	O
while	while	IN	B-SBAR	O
here	here	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
that	that	DT	B-NP	O
medicine	medicine	NN	I-NP	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
10-day	10-day	JJ	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
initial	initial	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
including	include	VBG	I-VP	O
hematuria	hematuria	NN	B-NP	O
,	,	,	O	O
resolved	resolve	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
-	-	HYPH	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabete	NNS	B-NP	O
requiring	require	VBG	B-VP	O
insulin	insulin	NN	B-NP	B-protein
treatment	treatment	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
endocrinologist	endocrinologist	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Kingnix	Kingnix	NNP	I-NP	O
Lowemar	Lowemar	NNP	I-NP	O
W.kell	W.kell	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
were	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
with	with	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
subcutaneous	subcutaneous	JJ	I-NP	O
injections	injection	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
the	the	DT	B-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
diabetes	diabetes	NN	I-NP	O
per	per	IN	B-PP	O
her	her	PRP$	B-NP	O
endocrinologist	endocrinologist	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Vitamin	Vitamin	NN	I-NP	O
C	C	NN	I-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
ferrous	ferrous	JJ	I-NP	O
sulfate	sulfate	NN	I-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
Lente	Lente	NNP	I-NP	O
subcutaneous	subcutaneous	JJ	I-NP	O
30	30	CD	I-NP	O
U	U	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
4	4	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
Regular	Regular	JJ	I-NP	O
subcutaneous	subcutaneous	JJ	I-NP	O
30	30	CD	I-NP	O
U	U	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	SYM	B-NP	B-protein
5	5	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
Synthroid	Synthroid	JJ	I-NP	O
200	200	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	SYM	B-NP	O
6	6	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Zaroxolyn	Zaroxolyn	NN	I-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
7	7	CD	I-NP	I-protein
-RRB-	-RRB-	:	O	O
tamoxifen	tamoxifen	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
8	8	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
Vitamin	Vitamin	NN	I-NP	I-protein
E	E	NN	I-NP	I-protein
400	400	CD	I-NP	I-protein
U	U	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.d.	q.d.	NN	I-NP	I-protein
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
9	9	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
Coumadin	Coumadin	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	FW	I-NP	I-protein
q.h.s.	q.h.s.	NN	I-NP	I-protein
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
multivitamins	multivitamin	NNS	I-NP	I-protein
1	1	CD	I-NP	I-protein
tablet	tablet	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.d.	q.d.	NN	I-NP	I-protein
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
11	11	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Zocor	Zocor	NNP	I-NP	I-protein
40	40	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	FW	I-NP	I-protein
q.h.s.	q.h.s.	NN	I-NP	I-protein
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	O
12	12	CD	I-NP	O
-RRB-	-RRB-	:	O	O
insulin	insulin	NN	B-NP	O
70/30	70/30	CD	B-NP	O
35	35	CD	I-NP	O
U	U	NN	I-NP	O
subcu	subcu	NN	I-NP	O
.	.	.	O	O

q.a.m.	q.a.m.	RB	B-ADVP	O
,	,	,	O	O
-LRB-	-LRB-	NNP	B-NP	O
13	13	CD	I-NP	O
-RRB-	-RRB-	SYM	O	O
Neurontin	Neurontin	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
2	2	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
,	,	,	O	O
300	300	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
14	14	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Serevent	Serevent	NNP	I-NP	I-protein
inhaled	inhale	VBD	B-VP	I-protein
1	1	CD	B-NP	I-protein
puff	puff	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
,	,	,	O	O
-LRB-	-LRB-	NNP	B-NP	O
15	15	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
torsemide	torsemide	NN	I-NP	O
100	100	CD	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
16	16	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Trusopt	Trusopt	NNP	I-NP	I-protein
1	1	CD	I-NP	I-protein
drop	drop	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
,	,	,	O	O
-LRB-	-LRB-	NNP	B-NP	O
17	17	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Flonase	Flonase	NN	I-NP	B-protein
nasal	nasal	JJ	I-NP	O
1-2	1-2	NN	I-NP	O
sprays	spray	NNS	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	O
18	18	CD	I-NP	O
-RRB-	-RRB-	:	O	O
Xalatan	Xalatan	NN	B-NP	O
1	1	CD	I-NP	O
drop	drop	NN	I-NP	O
ocular	ocular	JJ	B-ADJP	O
.	.	.	O	O

q.h.s.	q.h.s.	LS	B-LST	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
19	19	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Pulmicort	Pulmicort	NNP	I-NP	I-protein
inhaled	inhale	VBD	B-VP	I-protein
1	1	CD	B-NP	I-protein
puff	puff	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
,	,	,	O	O
-LRB-	-LRB-	NNP	B-NP	O
20	20	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Celebrex	Celebrex	NNP	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
21	21	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Avandia	Avandia	NNP	I-NP	O
4	4	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
22	22	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Hyzaar	Hyzaar	NNP	I-NP	O
12.5	12.5	CD	I-NP	O
mg/50	mg/50	NN	I-NP	O
mg	mg	NN	I-NP	O
1	1	CD	I-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
-LRB-	-LRB-	NNP	B-NP	O
23	23	CD	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
Nexium	Nexium	NN	I-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
-LRB-	-LRB-	SYM	B-NP	O
24	24	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
potassium	potassium	NN	I-NP	O
chloride	chloride	NN	I-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
-LRB-	-LRB-	NNP	B-NP	O
25	25	CD	I-NP	O
-RRB-	-RRB-	SYM	O	O
Suprax	Suprax	NN	B-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	FW	I-NP	O
x4	x4	CD	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
26	26	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
albuterol	albuterol	NN	I-NP	I-protein
inhaled	inhale	VBD	B-VP	I-protein
2	2	CD	B-NP	I-protein
puffs	puff	NNS	I-NP	I-protein
q.i.d.	q.i.d.	VBP	B-VP	O
p.r.n.	p.r.n.	NN	B-NP	O
wheezing	wheezing	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	O
27	27	CD	I-NP	O
-RRB-	-RRB-	:	O	O
miconazole	miconazole	NN	B-NP	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
powder	powder	NN	I-NP	O
applied	apply	VBD	B-VP	O
topically	topically	RB	B-ADVP	O
on	on	IN	B-PP	O
skin	skin	NN	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
for	for	IN	B-PP	O
itching	itch	VBG	B-NP	O
.	.	.	O	O

CONDITION	CONDITION	NN	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
stable	stable	JJ	B-ADJP	O
upon	upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
services	service	NNS	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	HYPH	O	O
Visiting	Visit	VBG	B-VP	O
nurse	nurse	NN	B-NP	O
on	on	IN	B-PP	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
5/6/02	5/6/02	CD	B-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
will	will	MD	B-VP	O
send	send	VB	I-VP	O
blood	blood	NN	B-NP	O
for	for	IN	B-PP	O
INR	INR	NN	B-NP	B-protein
and	and	CC	O	O
a	a	DT	B-NP	O
basic	basic	JJ	I-NP	O
metabolic	metabolic	JJ	I-NP	O
seven	seven	CD	I-NP	O
panel	panel	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
sent	send	VBN	I-VP	O
to	to	TO	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Silsbee	Silsbee	NNP	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
2	2	CD	B-NP	O
-RRB-	-RRB-	SYM	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Sedgwick	Sedgwick	NNP	I-NP	O
on	on	IN	B-PP	O
3/29/02	3/29/02	CD	B-NP	O
at	at	IN	B-PP	O
4	4	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
already	already	RB	I-VP	O
scheduled	schedule	VBN	I-VP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
HUGH	HUGH	NNP	B-NP	O
WRAIGHT	WRAIGHT	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
MF61	MF61	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ROMAN	ROMAN	NNP	B-NP	O
B.	B.	NNP	I-NP	O
ZAPANTA	ZAPANTA	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
GH7	GH7	NNP	I-NP	O
FR718/660166	FR718/660166	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
44789	44789	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

KHCHZS7N50	KHCHZS7N50	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
11/8/02	11/8/02	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
11/8/02	11/8/02	CD	B-NP	O

